Scott v. NaphCare

District Court, D. Nevada·Decided January 3, 2023·No. 3:19-cv-00347·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEVADA JAMES EDWARD SCOTT, Case No. 3:19-cv-00347-ART-CSD Plaintiff, ORDER REGARDING REPORT AND v. RECOMMENDATIONS ECF NOS. 112, 113, 114 NAPHCARE, et al.,

Defendants.

I. SUMMARY Pro se Plaintiff James Edward Scott (“Scott”), an inmate in the custody of the Nevada Department of Corrections (“NDOC”), brings this action under 42 U.S.C. § 1983 against Defendants Larry Williamson, M.D. (“Dr. Williamson”), Emily Feely, M.D. (“Dr. Feely”), Joshua Costello (“Costello”), and Officer Franklin (“Franklin”) for events that transpired while Scott was a pretrial detainee at the Clark County Detention Center (“CCDC”). (Compl., ECF No. 4). Before the Court are three Reports and Recommendations (“R&R”s) of United States Magistrate Judge Craig S. Denney recommending the Court grant Drs. Williamson and Feely’s Motion for Summary Judgment (ECF No. 112), grant Costello’s Motion for Summary Judgment (ECF No. 113) and deny Franklin’s Motion for Summary Judgment (ECF No. 114). Scott had until May 6, 2022, to file an objection. To date, no objections have been filed. This Court agrees with Judge Denney’s recommendations as to Defendants Dr. Feely, Costello, and Franklin and finds that Judge Denney did not clearly err with regard to these defendants. However, this Court also finds that Judge Denney did clearly err with regard to the recommendation as to Defendant Dr. Williamson as a dispute of material fact exists in the record as to whether Scott’s kidney injury was acute or chronic. Therefore, the Court adopts the R&Rs at ECF Nos. 113 and 114, and adopts-in- part and rejects-in-part the R&R at ECF No. 112. A. Facts Relevant to ECF No. 112 The Court incorporates by reference Magistrate Judge Denney’s recitation of Scott’s allegations in his complaint (ECF No. 4) provided in the R&R (ECF No. 112) with the following notes regarding the care given to Scott and the character of his kidney injury. On January 17, 2018, Dr. Williamson saw Scott for a chronic care visit regarding his hypertension. Scott’s blood pressure was high at 188/123 and the notes indicate that Scott was concerned about his high blood pressure. (ECF No. 85-1 at 17-24). Dr. Williamson noted that he would start Scott on lisinopril if his blood pressure remained elevated and ordered several laboratory tests (Id. at 22), including a “BMP” or “Basic Metabolic Panel”—a panel of tests including creatinine levels that indicate “waste products removed from your blood by your kidneys.” National Library of Medicine, Basic Metabolic Panel, MEDLINEPLUS (Mar. 9, 2021), https://medlineplus.gov/lab-tests/basic-metabolic-panel-bmp/ (last visited December 19, 2022). “A BMP is used to check different body functions and processes, including: kidney function. . . .” (Id.). Scott avers that no laboratory tests were performed until April 9, 2018—more than three months after he entered CCDC. (ECF No. 92 at 5). While Defendants Drs. Williamson and Feely note that laboratory tests were ordered on January 17, 2018, no results from these tests appear in the record. (See ECF No. 85 at 3). The earliest laboratory tests in Scott’s medical records are dated April 9, 2018. (ECF No. 85-1 at 27). On January 23, 2018, Dr. Williamson reviewed Scott’s blood pressure readings, which remained elevated. He prescribed lisinopril at 5mg, once a day. (ECF No. 85-1 at 25). Sixteen days later, on February 8, 2018, Dr. Williamson noted that Scott’s blood pressure was still high and doubled Scott’s lisinopril dose to 10 mg per day. (Id. at 26). Fifteen days later, on February 23, 2018, Dr. Williamson again noted Scott’s hypertension and again doubled his dose of lisinopril to 20 mg a day. (Id. at 26). Twenty days later, on March 15, 2018, Dr. Williamson again doubled Scott’s lisinopril dose to 40 mg a day after finding Scott’s blood pressure remained “a bit high.” (Id.). When Scott was transported to University Medical Center’s (“UMC”) Emergency Room on April 11, 2018, UMC staff noted that “Patient will require admission to the hospital for further workup regarding his acute renal failure.” (ECF No. 85-1 at 39). UMC nephrologist Raj Singh, M.D. performed a renal ultrasound on April 12, 2018, and Scott claims Dr. Singh told him that the 40 mg daily lisinopril “could be causing abnormalities in your kidney function.” (ECF No. 92 at 6). When Scott was discharged from UMC on April 18, 2018. His “principal discharge diagnosis” was “acute renal failure superimposed on stage 4 chronic kidney disease (CMS/HCC).” (Id. at 44). UMC staff adjusted Scott’s medications “based on kidney failure” (Id.) and did not prescribe him lisinopril. (Id. at 46-47). Upon return from UMC, Scott told Dr. Williamson he believed a medication caused his kidney failure in part because tests performed when he was released from the Indiana prison system four months prior to his incarceration at CCDC allegedly showed no abnormalities. (Id. at 60). Dr. Williamson referred Scott to a nephrologist—Dr. Feely. (Id.). Dr. Feely saw Scott via telemedicine on April 27, 2018. Her notes indicate that based on Scott’s history “this leans toward being an AKI [Acute Kidney Injury] but would need records from Indiana to confirm.” (Id.). The Indiana penitentiary provided minimal documentation that neither disclosed any significant health issues nor included any test results. (Id. at 79). Scott had another telemedicine appointment with Dr. Feely on June 13, 2018. (Id. at 80-81). Dr. Feely’s noted that “[Scott’s] renal disease appears to be chronic” and “suspect[ed] that this has been going on for a while.” (Id. at 81). She assessed him with “CKD [Chronic Kidney Disease] IV with proteinuria” and ordered a renal biopsy. (Id. at 80-81). Dr. Feely prescribed Scott lisinopril at 10 mg per day and discontinued metoprolol as prescribed by UMC. (Id. at 80). When Dr. Feely reviewed the results of the biopsy with Scott on July 13, 2022, she noted that the biopsy showed “severe glomerulosclerosis (91%) with interstitial fibrosis and mild-moderate arteriolonephrosclerosis. Secondary FSGS [Focal Segmental Glomerulosclerosis] was found but the cause is obviously unknown.” (Id. at 93- 94). After Scott left the custody of CCDC on November 8, 2018, he was transferred to High Desert State Prison (“HDSP”). Scott met with Dr. Bryant at HDSP. (ECF No. 92 at 8). Scott alleges Dr. Bryant told him: 1) lisinopril should not have been prescribed to Scott because he was Black and lisinopril is less effective in Black patients than in White patients; 2) lisinopril can raise creatinine levels “by allocating blood away from your kidneys and can impair your kidney function”; 3) lisinopril can cause kidney failure. (Id. at 8-9). Scott alleges Dr. Bryant discontinued lisinopril and prescribed Scott Norvasc and metoprolol. Based on this consultation with Dr. Bryant, Scott “realized his civil rights may have been violated” by Drs. Williamson and Feely, and took steps to initiate this lawsuit. (Id. at 9). Defendants’ expert Dr. James Felt concluded the biopsy results indicated “the presence of a long standing chronic kidney condition” that could have taken “many months to years to develop.” (Id. at 112-113). Dr. Felt opined that the management of Scott’s kidney disease met the standard of care. (Id.). The National Institute of Health’s (“NIH’s”) fact sheet on lisinopril notes “impaired renal function” under the heading “precautions” where it explains that “treatment with angiotensin converting enzyme inhibitors, including lisinopril, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure. . . .” (ECF No. 92 at 48). The NIH also notes that lisinopril and other angiotensin converting enzyme inhibitors (“ACE” inhibitors) “have an effect on blood pressure that is less in black patients than in non-blacks.” (Id. at 45). B. Facts Relevant to ECF No. 113

Free access — add to your briefcase to read the full text and ask questions with AI

Scott v. NaphCare, (D. Nev. 2023).

Scott v. NaphCare (Scott v. NaphCare) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

First Nat. Bank of Ariz. v. Cities Service Co.
391 U.S. 253 (Supreme Court, 1968)
Thomas v. Arn
474 U.S. 140 (Supreme Court, 1986)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Robin Orr v. Bank of America, Nt & Sa
285 F.3d 764 (Ninth Circuit, 2002)
Jonathon Castro v. County of Los Angeles
833 F.3d 1060 (Ninth Circuit, 2016)
Efrain Reynaga v. Roseburg Forest Products
847 F.3d 678 (Ninth Circuit, 2017)
Mary Gordon v. County of Orange
888 F.3d 1118 (Ninth Circuit, 2018)
Patrick Russell v. Jocelyn Lumitap
31 F.4th 729 (Ninth Circuit, 2022)
Balint v. Carson City
180 F.3d 1047 (Ninth Circuit, 1999)